Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: Insight from an in Silico study

Claudio Cobelli, Michele Schiavon, Chiara Dalla Man, Ananda Basu, Rita Basu

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Background: Glucose sensors measure glucose concentration in the interstitial fluid (ISF), remote from blood. ISF glucose is well known to be "delayed" with respect to blood glucose (BG). However, ISF glucose is not simply a shifted-in-time version of BG but exhibits a more complex pattern. Methods: To gain insight into this problem, one can use linear systems theory. However, this may lose a more clinical readership, thus we use simulation and two case studies to convey our thinking in an easier way. In particular, we consider BG concentration measured after meal and exercise in 12 healthy volunteers, whereas ISF glucose is simulated using a well-accepted model of blood-ISF glucose kinetics, which permits calculation of the equilibration time, a parameter characterizing the system. Two metrics are defined: blood and ISF glucose difference at each time point and time to reach the same glucose value in blood and ISF. Results: The simulation performed and the two metrics show that the relationship between blood-ISF glucose profiles is more complex than a pure shift in time and that the pattern depends on both equilibration time and BG. Conclusions: In this in silico study, we have illustrated, with simple case studies, the meaning of the of ISF glucose with respect to BG. Understanding that ISF glucose is not just a shifted-in-time version but a distorted mirror of BG is important for a correct use of continuous glucose monitoring for diabetes management.

Original languageEnglish (US)
Pages (from-to)505-511
Number of pages7
JournalDiabetes Technology and Therapeutics
Volume18
Issue number8
DOIs
StatePublished - Aug 1 2016

Fingerprint

Extracellular Fluid
Computer Simulation
Blood Glucose
Glucose
Systems Theory
Meals
Healthy Volunteers
Exercise

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Medical Laboratory Technology

Cite this

Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose : Insight from an in Silico study. / Cobelli, Claudio; Schiavon, Michele; Dalla Man, Chiara; Basu, Ananda; Basu, Rita.

In: Diabetes Technology and Therapeutics, Vol. 18, No. 8, 01.08.2016, p. 505-511.

Research output: Contribution to journalArticle

Cobelli, Claudio ; Schiavon, Michele ; Dalla Man, Chiara ; Basu, Ananda ; Basu, Rita. / Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose : Insight from an in Silico study. In: Diabetes Technology and Therapeutics. 2016 ; Vol. 18, No. 8. pp. 505-511.
@article{9cfc62943325468f8d43fde0d0edbf56,
title = "Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose: Insight from an in Silico study",
abstract = "Background: Glucose sensors measure glucose concentration in the interstitial fluid (ISF), remote from blood. ISF glucose is well known to be {"}delayed{"} with respect to blood glucose (BG). However, ISF glucose is not simply a shifted-in-time version of BG but exhibits a more complex pattern. Methods: To gain insight into this problem, one can use linear systems theory. However, this may lose a more clinical readership, thus we use simulation and two case studies to convey our thinking in an easier way. In particular, we consider BG concentration measured after meal and exercise in 12 healthy volunteers, whereas ISF glucose is simulated using a well-accepted model of blood-ISF glucose kinetics, which permits calculation of the equilibration time, a parameter characterizing the system. Two metrics are defined: blood and ISF glucose difference at each time point and time to reach the same glucose value in blood and ISF. Results: The simulation performed and the two metrics show that the relationship between blood-ISF glucose profiles is more complex than a pure shift in time and that the pattern depends on both equilibration time and BG. Conclusions: In this in silico study, we have illustrated, with simple case studies, the meaning of the of ISF glucose with respect to BG. Understanding that ISF glucose is not just a shifted-in-time version but a distorted mirror of BG is important for a correct use of continuous glucose monitoring for diabetes management.",
author = "Claudio Cobelli and Michele Schiavon and {Dalla Man}, Chiara and Ananda Basu and Rita Basu",
year = "2016",
month = "8",
day = "1",
doi = "10.1089/dia.2016.0112",
language = "English (US)",
volume = "18",
pages = "505--511",
journal = "Diabetes Technology and Therapeutics",
issn = "1520-9156",
publisher = "Mary Ann Liebert Inc.",
number = "8",

}

TY - JOUR

T1 - Interstitial fluid glucose is not just a shifted-in-time but a distorted mirror of blood glucose

T2 - Insight from an in Silico study

AU - Cobelli, Claudio

AU - Schiavon, Michele

AU - Dalla Man, Chiara

AU - Basu, Ananda

AU - Basu, Rita

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Background: Glucose sensors measure glucose concentration in the interstitial fluid (ISF), remote from blood. ISF glucose is well known to be "delayed" with respect to blood glucose (BG). However, ISF glucose is not simply a shifted-in-time version of BG but exhibits a more complex pattern. Methods: To gain insight into this problem, one can use linear systems theory. However, this may lose a more clinical readership, thus we use simulation and two case studies to convey our thinking in an easier way. In particular, we consider BG concentration measured after meal and exercise in 12 healthy volunteers, whereas ISF glucose is simulated using a well-accepted model of blood-ISF glucose kinetics, which permits calculation of the equilibration time, a parameter characterizing the system. Two metrics are defined: blood and ISF glucose difference at each time point and time to reach the same glucose value in blood and ISF. Results: The simulation performed and the two metrics show that the relationship between blood-ISF glucose profiles is more complex than a pure shift in time and that the pattern depends on both equilibration time and BG. Conclusions: In this in silico study, we have illustrated, with simple case studies, the meaning of the of ISF glucose with respect to BG. Understanding that ISF glucose is not just a shifted-in-time version but a distorted mirror of BG is important for a correct use of continuous glucose monitoring for diabetes management.

AB - Background: Glucose sensors measure glucose concentration in the interstitial fluid (ISF), remote from blood. ISF glucose is well known to be "delayed" with respect to blood glucose (BG). However, ISF glucose is not simply a shifted-in-time version of BG but exhibits a more complex pattern. Methods: To gain insight into this problem, one can use linear systems theory. However, this may lose a more clinical readership, thus we use simulation and two case studies to convey our thinking in an easier way. In particular, we consider BG concentration measured after meal and exercise in 12 healthy volunteers, whereas ISF glucose is simulated using a well-accepted model of blood-ISF glucose kinetics, which permits calculation of the equilibration time, a parameter characterizing the system. Two metrics are defined: blood and ISF glucose difference at each time point and time to reach the same glucose value in blood and ISF. Results: The simulation performed and the two metrics show that the relationship between blood-ISF glucose profiles is more complex than a pure shift in time and that the pattern depends on both equilibration time and BG. Conclusions: In this in silico study, we have illustrated, with simple case studies, the meaning of the of ISF glucose with respect to BG. Understanding that ISF glucose is not just a shifted-in-time version but a distorted mirror of BG is important for a correct use of continuous glucose monitoring for diabetes management.

UR - http://www.scopus.com/inward/record.url?scp=84983043937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983043937&partnerID=8YFLogxK

U2 - 10.1089/dia.2016.0112

DO - 10.1089/dia.2016.0112

M3 - Article

C2 - 27253751

AN - SCOPUS:84983043937

VL - 18

SP - 505

EP - 511

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

SN - 1520-9156

IS - 8

ER -